Shiaw‐Yih Lin

8.6k citations

78 papers · 6.3k indexed · 3 hit papers · h-index 36

Co-authors: Mien‐Chie Hung Weiya Xia Stephen J. Elledge Yong Wen Ka Yin Kwong Kaiyi Li Guang Peng Hui Dai
Topics: DNA Repair Mechanisms (34 papers)PARP inhibition in cancer therapy (13 papers)Cancer-related Molecular Pathways (11 papers)
Cited by: Oncology Cancer Research Molecular Biology
Journals: Cell Proceedings of the National Academy of Sciences Nucleic Acids Research
Partner nations: United States China Taiwan

In The Last Decade

Shiaw‐Yih Lin

77 papers receiving 6.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Nuclear localization of EGF receptor and its potential new role as a transcription factor

2001 863 citations Shiaw‐Yih Lin, Keishi Makino et al. Nature Cell Biology profile →
β-Catenin, a novel prognostic marker for breast cancer: Its roles in cyclin D1 expression and cancer progression

2000 672 citations Shiaw‐Yih Lin, Weiya Xia et al. profile →
Tumor microenvironment: barrier or opportunity towards effective cancer therapy

2022 212 citations Shiaw‐Yih Lin et al. profile →

Peers

Countries citing papers authored by Shiaw‐Yih Lin

Since Specialization

Citations

This map shows the geographic impact of Shiaw‐Yih Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shiaw‐Yih Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shiaw‐Yih Lin more than expected).

Fields of papers citing papers by Shiaw‐Yih Lin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shiaw‐Yih Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shiaw‐Yih Lin. The network helps show where Shiaw‐Yih Lin may publish in the future.

Co-authorship network of co-authors of Shiaw‐Yih Lin

This figure shows the co-authorship network connecting the top 25 collaborators of Shiaw‐Yih Lin. A scholar is included among the top collaborators of Shiaw‐Yih Lin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shiaw‐Yih Lin. Shiaw‐Yih Lin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	LBA54 SARS-CoV-2 mRNA vaccines sensitize tumors to immune checkpoint blockade 2025 ·Annals of Oncology ·Adam Grippin,(unknown),(unknown),N. Li,Christian Braun,C. Woody,Erin L. Young,(unknown),(unknown),Ryan Sun,Padmanee Sharma,J. Zhang,(unknown),Jennifer A. Wargo,(unknown),(unknown),(unknown),Wen Jiang,Elias Sayour,Shiaw‐Yih Lin	0
2	Neoadjuvant immunotherapy for oropharynx cancer: Correlative studies and long-term outcomes from the CIAO trial. 2024 ·Journal of Clinical Oncology ·Daniel J. McGrail,Kaiyi Li,(unknown),Faye M. Johnson,(unknown),Diana Bell,(unknown),Cara Haymaker,Adam S. Garden,Shiaw‐Yih Lin,J. Jack Lee,Maura L. Gillison,Neil D. Gross,Andrew G. Sikora,Renata Ferrarotto	1
3	Spatial Immunoprofiling of Adenoid Cystic Carcinoma Reveals B7-H4 Is a Therapeutic Target for Aggressive Tumors 2023 ·Clinical Cancer Research ·Luana Guimarães de Sousa,Daniel J. McGrail,Felippe Lazar Neto,Kaiyi Li,Mario L. Marques‐Piubelli,Sammy Ferri‐Borgogno,Hui Dai,Yoshitsugu Mitani,(unknown),Zachary A. Cooper,Krista Kinneer,María Angélica Cortez,Shiaw‐Yih Lin,Diana Bell,Adel K. El‐Naggar,Jared K. Burks,Renata Ferrarotto	12
4	Analysis of B7-H4 Expression Across Salivary Gland Carcinomas Reveals Adenoid Cystic Carcinoma–Specific Prognostic Relevance 2023 ·Modern Pathology ·(unknown),Yoshitsugu Mitani,(unknown),(unknown),Luana Guimarães de Sousa,Mario L. Marques‐Piubelli,Anurag Purushothaman,(unknown),Hui Dai,Shiaw‐Yih Lin,Michael T. Spiotto,Ehab Y. Hanna,Daniel J. McGrail,Adel K. El‐Naggar,Renata Ferrarotto	3
5	Widespread BRCA1/2-independent homologous recombination defects are caused by alterations in RNA-binding proteins 2023 ·Cell Reports Medicine ·Daniel J. McGrail,Yang Li,Roger S. Smith,Bin Feng,Hui Dai,Limei Hu,Briana K. Dennehey,(unknown),Marc L. Mendillo,Anil K. Sood,Gordon B. Mills,Shiaw‐Yih Lin,S. Stephen Yi,Nidhi Sahni	7
6	Combined Inhibition of Rad51 and Wee1 Enhances Cell Killing in HNSCC Through Induction of Apoptosis Associated With Excessive DNA Damage and Replication Stress 2021 ·Molecular Cancer Therapeutics ·Antje Lindemann,Ameeta A. Patel,Lin Tang,Noriaki Tanaka,Frederico O. Gleber‐Netto,(unknown),Li Wang,Daniel J. McGrail,Shiaw‐Yih Lin,Steven J. Frank,Mitchell J. Frederick,Jeffrey N. Myers,Abdullah A. Osman	18
7	Replication stress response defects are associated with response to immune checkpoint blockade in nonhypermutated cancers 2021 ·Science Translational Medicine ·Daniel J. McGrail,Patrick G. Pilié,Hui Dai,Truong Lam,Yulong Liang,Leonie Voorwerk,Marleen Kok,Xiang H.-F. Zhang,Jeffrey M. Rosen,Amy B. Heimberger,Christine B. Peterson,Eric Jonasch,Shiaw‐Yih Lin	22
8	Integrated Genomic Characterization of the Human Immunome in Cancer 2020 ·Cancer Research ·(unknown),(unknown),Daniel J. McGrail,Ming Sun,Dan Qi,Sachet A. Shukla,Erxi Wu,Anna Capasso,Shiaw‐Yih Lin,Catherine J. Wu,S. Gail Eckhardt,Gordon B. Mills,Bo Li,Nidhi Sahni,S. Stephen Yi	10
9	Proteogenomic Analysis of Salivary Adenoid Cystic Carcinomas Defines Molecular Subtypes and Identifies Therapeutic Targets 2020 ·Clinical Cancer Research ·Renata Ferrarotto,Yoshitsugu Mitani,Daniel J. McGrail,Kaiyi Li,Tatiana V. Karpinets,Diana Bell,Steven J. Frank,Xingzhi Song,Michael E. Kupferman,Bin Liu,J. Jack Lee,Bonnie S. Glisson,Jianhua Zhang,Jon C. Aster,Shiaw‐Yih Lin,P. Andrew Futreal,John V. Heymach,Adel K. El‐Naggar	87
10	Rational combination therapy with PARP and MEK inhibitors capitalizes on therapeutic liabilities in RAS mutant cancers 2017 ·Science Translational Medicine ·(unknown),Yong Fang,Jun‐Jie Yin,Jian Chen,Zhenlin Ju,Dong Zhang,Xiaohua Chen,Christopher P. Vellano,Kang Jin Jeong,Patrick Kwok‐Shing Ng,Agda Karina Eterovic,Neil E. Bhola,Yiling Lu,Shannon N. Westin,Jennifer R. Grandis,Shiaw‐Yih Lin,Kenneth L. Scott,Guang Peng,Joan S. Brugge,Gordon B. Mills	170
11	mTOR Inhibitors Suppress Homologous Recombination Repair and Synergize with PARP Inhibitors via Regulating SUV39H1 in BRCA-Proficient Triple-Negative Breast Cancer 2015 ·Clinical Cancer Research ·Wei Mo,Qingxin Liu,Curtis Chun-Jen Lin,Hui Dai,Yang Peng,Yulong Liang,Guang Peng,Funda Meric‐Bernstam,Gordon B. Mills,Kaiyi Li,Shiaw‐Yih Lin	90
12	TUSC4 Functions as a Tumor Suppressor by Regulating BRCA1 Stability 2014 ·Cancer Research ·Yang Peng,Hui Dai,Wenge Wang,Curtis Chun-Jen Lin,Wei Mo,Guang Peng,Shiaw‐Yih Lin	26
13	BRIT1 regulates p53 stability and functions as a tumor suppressor in breast cancer 2013 ·Carcinogenesis ·Bo Zhang,Wenge Wang,Hui Dai,Ruozhen Hu,Yulong Liang,Kaiyi Li,Guobin Wang,Guang Peng,Shiaw‐Yih Lin	13
14	Human Nuclease/Helicase DNA2 Alleviates Replication Stress by Promoting DNA End Resection 2012 ·Cancer Research ·Guang Peng,Hui Dai,Wei Zhang,(unknown),Mei‐Ren Pan,Yun‐Yong Park,Robert Y. L. Tsai,Isabelle Bedrosian,Ju‐Seog Lee,Grzegorz Ira,Shiaw‐Yih Lin	64
15	Dual Functions of the Homeoprotein DLX4 in Modulating Responsiveness of Tumor Cells to Topoisomerase II-Targeting Drugs 2012 ·Cancer Research ·(unknown),Song Yi Ko,Nicolas Barengo,Shiaw‐Yih Lin,Honami Naora	20
16	TRF2 functions as a protein hub and regulates telomere maintenance by recognizing specific peptide motifs 2009 ·Nature Structural & Molecular Biology ·Hyeung Kim,Ok-Hee Lee,Huawei Xin,Liuh‐Yow Chen,Jun Qin,(unknown),Shiaw‐Yih Lin,(unknown),Dan Liu,Zhou Songyang	105
17	Rak Functions as a Tumor Suppressor by Regulating PTEN Protein Stability and Function 2009 ·Cancer Cell ·Eun-Kyoung Yim,Guang Peng,Hui Dai,Ruozhen Hu,Kaiyi Li,Yiling Lu,Gordon B. Mills,Funda Meric‐Bernstam,Bryan T. Hennessy,Rolf J. Craven,Shiaw‐Yih Lin	152
18	Nuclear localization of EGF receptor and its potential new role as a transcription factorbreakdown → 2001 ·Nature Cell Biology ·Shiaw‐Yih Lin,Keishi Makino,Weiya Xia,Angabin Matin,Yong Wen,Ka Yin Kwong,Lilly Bourguignon,Mien‐Chie Hung	863
19	HER-2/neu Blocks Tumor Necrosis Factor-induced Apoptosis via the Akt/NF-κB Pathway 2000 ·Journal of Biological Chemistry ·Binhua P. Zhou,Mickey C.‐T. Hu,Stephanie A. Miller,Zhenming Yu,Weiya Xia,Shiaw‐Yih Lin,Mien‐Chie Hung	322
20	Cell Cycle-Regulated Association of E2F1 and Sp1 Is Related to Their Functional Interaction 1996 ·Molecular and Cellular Biology ·Shiaw‐Yih Lin,Adrian R. Black,(unknown),Sanja Pajovic,(unknown),Jane Clifford Azizkhan	244

About Shiaw‐Yih Lin

Shiaw‐Yih Lin is a scholar working on Oncology, Aging and Cancer Research, having authored 78 papers that have together received 6.3k indexed citations. Recurring topics across this work include DNA Repair Mechanisms (34 papers), PARP inhibition in cancer therapy (13 papers) and Cancer-related Molecular Pathways (11 papers). The work is most often cited by research in Oncology (2.4k citations), Cancer Research (1.1k citations) and Molecular Biology (4.8k citations). Shiaw‐Yih Lin has collaborated with scholars based in United States, China and Taiwan. Frequent co-authors include Mien‐Chie Hung, Weiya Xia, Stephen J. Elledge, Yong Wen, Ka Yin Kwong, Kaiyi Li, Guang Peng, Hui Dai, Lilly Bourguignon and Keishi Makino. Their work appears in journals such as Cell, Proceedings of the National Academy of Sciences and Nucleic Acids Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact